<SEC-DOCUMENT>0001279569-19-000398.txt : 20190225
<SEC-HEADER>0001279569-19-000398.hdr.sgml : 20190225
<ACCEPTANCE-DATETIME>20190225101245
ACCESSION NUMBER:		0001279569-19-000398
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190222
FILED AS OF DATE:		20190225
DATE AS OF CHANGE:		20190225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		19628346

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 3pt">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 12pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&nbsp;6-K </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>REPORT OF FOREIGN ISSUER </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO RULE 13a-16 OR 15d-16
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF
1934 </b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>For the month of February 2019</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Commission File No.&nbsp;001-38496</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Canopy Growth Corporation</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>1 Hershey Drive<br>
Smith Falls, Ontario<br>
K7A 0A8</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files
or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font>
<font style="font-family: Times New Roman, Times, Serif">Form 40-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(1):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(7):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant by furnishing
the information contained in this Form&nbsp;is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b)&nbsp;under
the Securities Exchange Act of 1934.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font>
<font style="font-family: Times New Roman, Times, Serif">&nbsp;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 3pt; margin-bottom: 12pt"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 8%">&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 90%">&nbsp;</td></tr>
<tr>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exhibit</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td>
    <td>&nbsp;</td>
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Description</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr style="vertical-align: top">
    <td nowrap style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">99.1</A></FONT></td>
    <td><FONT STYLE="color: Black">&nbsp;</FONT></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">Press
    Release - Canopy Growth Appoints Dr. Danial Schecter as Director, Global Medical Services</A></FONT></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><u></u></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 43%">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canopy Growth Corporation</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Bruce Linton</p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Linton</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Date: February 22, 2019</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">2</p>




<p style="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED FEBRUARY 22, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth Appoints Dr. Danial Schecter
as Director, Global Medical Services</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SMITHS FALLS, ON, Feb. 22, 2019 /CNW/ -&nbsp;Canopy
Growth Corporation (&quot;Canopy Growth&quot; or the &quot;Company&quot;) (TSX: WEED) (NYSE: CGC) is pleased to announce the appointment
of Dr. Danial Schecter as Director of Global Medical Services. Dr. Schecter is widely recognized as an expert in the clinical use
of medical cannabis and will use his experience to expand the Company's network of partner healthcare clinics and support doctors
and patients who understand the value of cannabis as medicine.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT="Canopy Growth Appoints Dr. Danial Schecter as Director, Global Medical Services (CNW Group|Canopy Growth Corporation)" STYLE="height: 84px; width: 282px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth Appoints Dr. Danial Schecter
as Director, Global Medical Services (CNW Group/Canopy Growth Corporation)</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;I have had the honour of serving a range
of patients who, after exhausting traditional pharmaceutical approaches, have reported the remarkable benefits of therapeutic cannabis,&quot;
said Dr. Schecter. &quot;As Canopy Growth's new Director of Global Medical Services, it will be my privilege to share the lessons
learned from my vast clinical experience to benefit new cohorts of physicians and patients, both nationally and globally, who are
able to access federally regulated medical cannabis.&quot;&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Dr. Schecter's approach will rely on educational
and outreach activities, including establishing new mentorship opportunities, developing training modules and organizing advisory
boards that will assist healthcare providers in each jurisdiction that allows medical cannabis access. In addition, he will identify
and support clinics partnered with Spectrum Cannabis and ensure they operate at the highest standards.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;Dr. Schecter will leverage his extraordinary
wealth of front-line clinical experience as we expand the Company's medical cannabis practice into new jurisdictions,&quot; said
Dr. Mark Ware, Chief Medical Officer, Canopy Growth. &quot;We look forward to working with him as we continue our efforts to educate
physicians and other healthcare providers who are committed to ensuring patients get the access to medical cannabis they deserve.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Prior to being appointed to his new role at
Canopy Growth, Dr. Schecter was the co-founder and Executive Director of Canabo Medical Clinics, the largest referral-only clinic
network specializing in medical cannabis in Canada. He trained thousands of physicians and pharmacists on how to help patients
decide if cannabis was the appropriate treatment for their specific medical conditions. Outside of cannabinoid medicine, he holds
a fellowship in Hospital Medicine and is an active hospitalist at the Royal Victoria Regional Health Centre in Barrie, Ontario.
Dr. Schecter is also a practicing family physician who will continue to provide house calls to at-risk elderly and palliative care
patients.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Dr. Schecter's experience as a patient-focused
family physician and leader in the medical cannabis sector makes him a welcome addition to Canopy Growth's team of healthcare professionals
and industry experts. Their combined efforts will further the Company's mission to provide reliable, consistent medical cannabis
products that will improve the lives of patients around the world.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Here's to Future (medical) Growth.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B><BR>
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties
in dried, oil and Softgel capsule forms. Canopy Growth offers medically approved vaporizers through the Company's subsidiary, Storz
&amp; Bickel GMbH &amp; Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has
operations in over a dozen countries across five continents.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company is proudly dedicated to educating
healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through
its wholly owned subsidiary, Canopy Health Innovations (&quot;Canopy Health&quot;), has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy
Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property
protection. Canopy Growth acquired assets of leading hemp research company, ebbu, Inc. (&quot;ebbu&quot;). Intellectual Property
(&quot;IP&quot;) and R&amp;D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis
genetic breeding program and its cannabis-infused beverage capabilities. Through partly owned subsidiary Canopy Rivers Corporation,
the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the
sector.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, Battelle, the world's largest nonprofit research
and development organization, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten
licensed cannabis production sites with over 4.3 million square feet of production capacity, including over 500,000 square feet
of GMP certified production space. The Company operates Tweed retail stores in Newfoundland and Manitoba and has entered into supply
agreements with every Canadian province and territory. For more information visit www.canopygrowth.com</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements</B><BR>
This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to expand the Company's network of partner healthcare
clinics and support doctors and patients, and establishing new mentorship opportunities, developing training modules and organizing
advisory boards. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results,
performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information,
including expanding internationally and growing patient numbers, and such risks contained in the Company's annual information form
dated June 27, 2018 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com.
Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking
statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements
included in this news release are made as of the date of this news release and the Company does not undertake an obligation to
publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/February2019/25/c7471.html</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Caitlin O'Hara, Media Relations,
Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.
122; Director: Bruce Linton, tmx@canopygrowth.com</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 09:00e 22-FEB-19</P>



<P STYLE="margin: 0; text-align: left"></p>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !4 1H# 2(  A$! Q$!_\0
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M^11Y[^W_ 'R* &44_P ]_;_OD4>>_M_WR* &44_SW]O^^13DF<NH.W!(_A%
M$5.'2B3_ %C?4T#I0!]>4U/X_P#>-.IJ?Q_[QK$L>.HKS.X@%QKUY)(?NS,
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MK7VB"TTY+I;D29"%D*$8#@D<]^E9-4I*6PFFMPI55FSM!.!D^PI*GM?NS_\
M7(_S%-B(**** "B@*6("@DGL*MV6GSW=TD2PRG)YVKR!WH BM[.XNB1;PR2$
M==JYJ)D9&*NI5AU!&#7IMC;6L%OY%A'(@+ L=NT_G3K^QLM1A:&:)7<C'F@
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MZI0\:D$1]#_>H ;)_K&^IH'2D8[F)]32CI0!]>5X;XYG>?Q7J;2')6;8/H
M***S197\*(&U0Y'1*ZSQ!<26VA7,D1VMC;GTR0/Y&BBNB'PDO<\VDZ ?A1VH
MHK L<*AS]X]\FBB@!Q/S!>U+']S/KFBB@#U?XEL6^$BD]2+;^E>!444X[$,*
M***H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %.
''2BB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
